April 20, 2025 – Another
Attack on My Body
I mentioned
that in August, 2024 my new oncologist ordered a CT scan for March 10th. I must admit that I was nervous for the next
six months for what they might find. At
my insistence, I had both a full body CT scan and full body bone scan. This was because I remember that in 2016 when
they discovered the Stage IV prostate cancer there was some activity in the
skull.
Unfortunately
they found several things. There was a
tumor surrounding one of my kidney ureters and some activity in some lymph nodes. The oncologist asked my urologist remove the
tumor and install a stent to protect the flow through the ureter. The next week I had the surgery. On the day of the surgery I received a call
telling me that my urologist was admitted to the hospital and another urologist
would perform the surgery. This
urologist has a good reputation, much like my urologist, but he know only a
limited amount of my history. The
important part is my problems with that sphincter muscle. I begged him to be careful with it, but I
think my urologist would have taken this more to heart.
Post Surgery
The surgery
was laparoscopic, so it had to go through that sphincter muscle. When I was recovering was when I first heard
that the urologist had removed a tumor and had dilated my urethra. Of course I wanted to know more about the
tumor, but I haven’t seen the urologist since the operation. I really miss my regular urologist. He is out of commission for the next few
months.
Unfortunately,
that precious sphincter muscle didn’t make it unscathed. As a result, the spigot is now always open,
leaving me incontinent. To anyone who
has found themselves in this condition, I now agree that it is worse than all
of the above that has happened to me because it has changed my lifestyle. The urologist said there is a chance I will
regain control. I certainly hope so
because this truly sucks. I’m becoming
an expert on all that is available for this condition.
Back to the
tumor…
My oncologist ordered chemo to start a week after the diagnosis, with
the assumption that the tumor was prostate cancer (reasonable assumption). My oncologist was going to treat it with
Docetaxel, the same chemo I had before.
The infusion would be every six weeks in Charleston. I balked and said I needed a week or two to
get my ducks in a row. I wanted a second
opinion and I wanted to know more about the tumor. He agreed with the delay.
Then I had to
chase the pathologist who worked for the urologist in a different hospital
system. After two weeks I was impatient,
so I just showed up at the urologist’s office to light a fire to get the
report.
By that time,
with the help of my MUSC oncologist, I was referred to a local oncologist, Dr.
Bakos, who is a member South Carolina Cancer Specialists, a group under St.
Joseph’s Candler Hospitals. The main SJC
hospital is in Savannah. I am very
familiar with St. Joseph’s, having had one of their doctors as my primary care
doctor. I had tried to get into their
oncology group when I moved to South Carolina but was turned down. I will now have the best of both worlds. Dr. Ho at MUSC and Dr. Bakos at St. Joseph’s
(10 minutes away) will work together on my case.
The pathology
report was a surprise to all of us. The
tumor is bladder cancer, not prostate cancer.
It is a good thing that I delayed the chemo because the treatment for
bladder cancer is very different from prostate cancer!
Bladder
Cancer is no picnic. It tends to grow
fast and it directly affects quality-of-life.
What is also bad about it is that it frequently goes undetected for a
long time. The ultimate treatment is to remove the bladder, which I am trying
to avoid by having chemo treatments. Bladder Cancer has stages just like all
cancers. Mine is PT2, which I believe
means that it has invaded the bladder muscular wall. There is also some evidence of activity in
local lymph glands and the lungs, so it is likely metastatic (spreading through
the blood). This dictates the therapy to
be chemotherapy. The good news is that
there is a chemo treatment that is quite new but has had excellent
results. This is the Enfortumab
Vedotin and Pembrolizumab combination, which was only recently been approved
by the FDA. This is also known as the PADCEV/Keytruda combination. This is what my doctors are prescribing and
they got Medicare approval for it. The
approval took a couple of weeks. The PADCEV
portion specifically targets an element in bladder cancer. Keytruda is an immunotherapy drug. This combination has a survival rate of
around 79% compared to 52% for other chemotherapy. I do like those odds.
Les